Keynote Speakers

Dr Ildem Akerman, PhD

Institute of Metabolism and Systems Research
Member of the 2017/18 Birmingham Fellows

Dr Akerman is interested in answering fundamental questions about gene regulation in diseased and healthy pancreatic beta cells through integrated use of molecular, genomic, computational and systems biology. In particular, her aim is to understand how various types of noncoding DNA elements interact to establish gene expression in the pancreatic beta cell.

View Dr Ildem Akerman's full profile.

 

Dr Ildem Akerman, PhD

Professor Wiebke Arlt, MD DSc FRCP FMedSci

Institute of Metabolism and Systems Research
William Withering Chair of Medicine
Director of the Institute of Metabolism and Systems Research

Professor Arlt leads a large, multi-disciplinary research group, comprising biologists, biochemists, clinician scientists and computational biologists, investigating the regulation and role of steroid metabolism and action in health and disease. As an Honorary Consultant Endocrinologist, she leads specialist services for patients with adrenal and gonadal disorders at the Queen Elizabeth Hospital Birmingham, as part of the Birmingham Health Partners Centre for Endocrinology, Diabetes and Metabolism (CEDAM).

View Professor Wiebke Arlt's full profile.

 

Wiebke-Arlt-Feb2018-cropped

Dr Kristien Boelaert, MD, PhD, MRCP

Institute of Metabolism and Systems Research
Reader in Endocrinology

Dr Boelaert is a Senior MRC-funded Research Fellow and practising Consultant Endocrinologist with lead roles in the Thyroid Services at the UHB NHS Foundation Trust. Her laboratory research interests focus on the pathogenesis of thyroid cancer and in particular on the identification of novel diagnostic and therapeutic approaches for patients with thyroid cancer and goitre. In addition, she has a wide interest in clinical and translational research including the management of thyroid dysfunction and thyroid nodules.

View Dr Kristien Boelaert's full profile.

 

Dr Kristien Boelaert, MD, PhD, MRCP

Dr Rowan Hardy, BMedSc, PgC, PhD

Institute of Metabolism and Systems Research
ARUK Career Development Fellow

Dr Hardy is an early career scientist specialising in steroid metabolism, with extensive experience in inflammatory animal models. Having recently received a prestigious Career Development Fellowship he is now establishing a research group focussing on the roles of glucocorticoid signalling in inflammatory disease, examining a role for therapeutic agents that modify glucocorticoid signalling.

View Dr Rowan Hardy's full profile.

 

Dr Rowan Hardy, BMedSc, PgC, PhD

Dr Muhammad A Karamat, MD

Consultant in Endocrinology, Diabetes and Metabolism Heart of England NHS Foundation Trust, Birmingham

Dr Karamat is a consultant in diabetes and endocrinology at the Heart of England NHS Foundation Trust and an honorary senior lecturer at the University of Birmingham. He completed his higher specialist training in diabetes and endocrinology as a clinical lecturer at University of Birmingham. During this tenure he also completed an M.D. in the role of non-invasive screening methods in detecting diabetes mellitus. He has particular interest in antenatal diabetes and intensive insulin therapy. He runs weekly antenatal diabetes and insulin pump clinics at both Heartlands and Solihull Hospitals as well as jointly leading the regional islet transplant MDT clinic with colleagues from Oxford and Birmingham. In addition he has published in the field of diabetes management during Ramadan, antenatal diabetes, diabetes and cardiovascular disease and intensive insulin therapy as well as non-alcoholic fatty liver disease.

View Dr Muhammad A Karamat's full profile

Muhammed Karamat

Dr Konstantinos Manolopoulos, MD, PhD

Institute of Metabolism and Systems Research
Hoffenberg Clinician Scientist in Endocrinology and Human Metabolism

Dr Manolopoulos is a Clinician Scientist in Endocrinology with a research interest in human in vivo metabolic physiology. He is exploring the hormonal determinants of adipose tissue function, and is particularly interested in the factors causing adipocyte dysfunction in obesity. Furthermore, he investigates the cross-talk between adipose tissue and other organs such as gut, liver and muscle. He is responsible for the Human Integrative Physiology and Metabolism lab at the NIHR/Wellcome Trust Clinical Research Facility.

View Dr Konstantinos Manolopoulos's full profile.

 

Dr Konstantinos Manolopoulos, MD, PhD

Dr Parth Narendran, FRCP PhD
Institute of Immunology and Immunotherapy
Reader in Diabetes Medicine
Honorary Consultant Physician

Parth is a qualified clinician by background. His research is primarily on type 1 diabetes, in particular on how to preserve the function of insulin producing pancreatic beta cells.

He is currently the co-lead for the West Midlands Clinical Research Network and was previously the diabetes theme lead for the Birmingham and Black Country Clinical Research Network from 2010-14. He leads the Diabetes Research Unit and the Type 1 Diabetes clinical service at the Queen Elizabeth Hospital. He is the author of over 50 peer-reviewed publications including publications that have been cited by international bodies on Type 1 diabetes and its management. He currently sits on the Diabetes UK Research Committee and was previously on the Research Advisory Board of the Diabetes Research and Wellness Foundation and Regional Advisory Committee for the NIHR RfPB programme. Parth reviews for all the major national and international diabetes journals. He contributes to the NIHR Horizon Scanning, and NICE Medical Technology reviews for new therapies. 

View Dr Parth's staff profile

Parth-Narendran

Dr Michael O'Reilly, FRCPI, PhD

Department of Endocrinology
Beaumont Hospital, Dublin, Ireland

Dr O’Reilly’s research focuses on the metabolic consequences of androgen excess in women, with a focus on adipose tissue dysfunction. He also studies the sexually dimorphic impact of androgens on human metabolic health, looking specifically at the overlapping adverse metabolic phenotype of women with androgen excess and men with androgen deficiency. He has a clinical subspecialist interest in polycystic ovary syndrome, adrenal tumours and endocrine infertility.

View Dr Michael O'Reilly's full profile.

 

Dr Michael O'Reilly, FRCPI, PhD

Dr Abd Tahrani, MD, MMedSci, PhD, FRCP

Institute of Metabolism and Systems Research
NIHR Clinician Scientist at the University of Birmingham
Honorary Consultant in Obesity, Diabetes and Endocrinology at University Hospitals Birmingham NHS Foundation Trust.
Lead for Weight Management Research and Diabetic Neuropathy Services at Birmingham Heartlands Hospital

Dr Tahrani leads a multi-disciplinary research group that include scientists, clinicians and allied health-care professionals. The aims of this research group are to: examine the impact of sleep-related disorders (including obstructive apnoea) on metabolic health, diabetes and obesity; improve our understanding of the pathogenesis of diabetes-related microvascular complications (peripheral neuropathy, autonomic neuropathy, nephropathy, retinopathy) and to identify new treatment targets and effective screening strategies; improve our understanding of the pathogenesis of foot ulceration in diabetes and develop new treatments; explore the pharmacological and non-pharmacological options to treat and manage patients with obesity (including the long-term outcomes of bariatric surgery); develop new treatments for type 2 diabetes.

View Dr Abd Tahrani's full profile.

Dr Abd Tahrani, MD, MMedSci, PhD, FRCP